|
|
Dermatology
Impact of the Severity of Pediatric Psoriasis on Childhood Body Mass Index and Comorbid Risk Factors: an Epidemiologic Analysis
Principal Investigator: Amy Paller, MD
Contact: Anne Mahoney, MD
Phone: 773-327-3326
E-mail: AMahoney@childrensmemorial.org
ClinicalTrials.gov Identifier: NCT00879944; IRB Number: 2009-13793
Open-label, Pilot study to Investigate the Safety and Tolerability of Alwextin 3.0% Cream in the Treatment of Epidermolysis Bullosa
Principal Investigator: Amy Paller, MD
Contact: Amanda Silverio, MD
Phone: (773) 327-9642
E-mail: ASilverio@childrensmemorial.org
ClinicalTrial.gov Identifier: NCT00825565; IRB Number 2009-13625
Study to Demonstrate the Efficacy and Safety of Propranolol Oral Solution in Infants With Proliferating Infantile Hemangiomas Requiring Systemic Therapy (HEMANGIOL)
Principal Investigator:Anthony J. Mancini, MD
Contact: Anne Mahoney, MD
Phone: (773) 327-3326
E-mail: AMancini@northwestern.edu; AMahoney@childrensmemorial.org
ClinicalTrials.gov Identifier: NCT01056341; IRB Number 2010
Genetic Screening for Filaggrin mutation in Atopic Dermatitis and Ichthyosis Vulgaris in the African American Popluation
Principal Investigator: Amy Paller, MD
Contact: Amanda Silverio, MD
Phone: (773) 327-9642
E-mail: ASilverio@childrensmemorial.orgClinicalTrials.gov Identifier: NCT01016106; IRB Number 2010-14049
ADVN Biomarker Registry Study
Condition: Atopic Dermatitis
Principal Investigator: Amy Paller, MD
Contact: Anne Mahoney,MD
Phone: 773-327-3326
Email: AMahoney@childrensmemorial.org
ClinicalTrials.gov identifier: NCT00550316; IRB Number: 2008-13500/13508
Identifying Genetic Determinants of Eczema Herpeticum and Other Viral Infections in Individuals With Atopic Dermatitis (Genetics)
Principal Investigator: Amy Paller, MD
Contact: Anne Mahoney. MD
Phone: 773-327-3326
Email: AMahoney@childrensmemorial.org
ClinicalTrials.gov identifier: NCT00515047
Safety and Efficacy of TACLONEX Ointment in Adolescent Patients (Aged 12 to 17 Years) With Psoriasis Vulgaris
Principal Investigator: Amy Paller, MD
Contact: Amanda Silverio, MD
Phone: (773) 327-9642
E-mail: ASilverio@childrensmemorial.org
ClinicalTrials.gov Identifier: NCT00817219
Effect of Thymosin Beta 4 on Wound Healing in Patients With Epidermolysis Bullosa
Principal Investigator: Amy Paller, MD
Contact: Anne Mahoney, MD
Phone: (773) 327-3326
E-mail: AMahoney@childrensmemorial.org
ClinicalTrials.gov Identifier: NCT00311766; IRB # 2006-12938
An Open-label Extension Study to Evaluate the Safety of Etanercept in Pediatric Subjects with Plaque Psoriasis
Principal Investigator: Amy Paller, MD
Contact Person : Amanda Silverio, MD
Phone number: 773-327-9642Email: ASilverio@childrensmemorial.org
ClinicalTrials.gov Identifier: NCT00141921 (IRB Number: 2005-12643)
Genetic Screening for Dermatologic Diseases
Principal Investigator: Amy Paller, MD
Contact Person: Amanda Silverio, MD
Email: ASilverio@childrensmemorial.org
Phone number: 773-327-9642
IRB Number: 2009-13803
A Pilot Study of reduced Intensity Conditioning (RIC) and Allogeneic Stem Cell Transplantation (ALLOSCT) in Children with Recessive Dystrophic Epidermolysis Bullosa (RDEB)Principal Investigator: Amy Paller, MD
Contact Person: Anne Mahoney, MD
Email: AMahoney@childrensmemorial.org
Phone number: 773-327-3326
IRB Number: 2009-13907
APPLES: A Prospective Pediatric Longitudinal Evaluation to Assess the Long-term Safety of Tacrolimus Ointment for the Treatment of Atopic Dermatitis.
Principal Investigator: Amy Paller, MD
Contact Person: Amanda Silverio, MD
Email: ASilverio@childrensmemorial.org
Phone number: 773-327-9642
ClinicalTrials.gov Identifier: NCT00475605 (IRB Number: 2005-12622)
Childhood Atopic Dermatitis Impact Scale (CADIS)
Back to the top of the page
|